Compile Data Set for Download or QSAR
maximum 50k data
Found 20 Enz. Inhib. hit(s) with all data for entry = 50012516
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119826(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)
Affinity DataIC50:  7.60E+3nMAssay Description:Inhibitory concentration of the compound against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119832(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)
Affinity DataIC50:  7.90E+3nMAssay Description:Inhibitory concentration of the compound against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119858(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50:  1.08E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119858(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50:  1.08E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119855(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  1.36E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119855(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  1.36E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119842(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)
Affinity DataIC50:  3.54E+4nMAssay Description:Inhibitory concentration of the compound against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119853(2-{[(1S,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  7.20E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119860(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  7.80E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119857(CHEMBL108067 | [(S)-3-((S)-6-Amino-purin-9-yl)-cyc...)
Affinity DataIC50:  7.90E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119821(2-[3-(6-Amino-purin-9-yl)-propoxy]-N-hydroxy-aceta...)
Affinity DataIC50:  9.40E+4nMAssay Description:Inhibitory concentration of the compound against type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119854(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  9.60E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119861(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  9.80E+4nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119854(2-{[(1R,4S)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50:  1.02E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119851(2-[(R)-3-((R)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50:  1.10E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119856(CHEMBL106689 | [(R)-3-((R)-6-Amino-purin-9-yl)-cyc...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119859(2-{[(1R,3R)-3-(6-amino-9H-purin-9-yl)cyclopentyl]o...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119850(2-{[(1R,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119852(2-{[(1S,3S)-3-(6-amino-9H-purin-9-yl)cyclopentyl]o...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenylate cyclase type 5(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50119851(2-[(R)-3-((R)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibitory concentration of the compound against Type V Adenyl Cyclase enzymeMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed